These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 22155399)

  • 1. Characterization of [³H]Lu AE60157 ([³H]8-(4-methylpiperazin-1-yl)-3-phenylsulfonylquinoline) binding to 5-hydroxytryptamine₆ (5-HT₆) receptors in vivo.
    Witten L; Bang-Andersen B; Nielsen SM; Miller S; Christoffersen CT; Stensbøl TB; Brennum LT; Arnt J
    Eur J Pharmacol; 2012 Feb; 676(1-3):6-11. PubMed ID: 22155399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.
    Arnt J; Bang-Andersen B; Grayson B; Bymaster FP; Cohen MP; DeLapp NW; Giethlen B; Kreilgaard M; McKinzie DL; Neill JC; Nelson DL; Nielsen SM; Poulsen MN; Schaus JM; Witten LM
    Int J Neuropsychopharmacol; 2010 Sep; 13(8):1021-33. PubMed ID: 20569520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
    Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.
    Maier DL; Sobotka-Briner C; Ding M; Powell ME; Jiang Q; Hill G; Heys JR; Elmore CS; Pierson ME; Mrzljak L
    J Pharmacol Exp Ther; 2009 Jul; 330(1):342-51. PubMed ID: 19401496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosynthesis and characterization of 11C-GSK215083 as a PET radioligand for the 5-HT6 receptor.
    Parker CA; Gunn RN; Rabiner EA; Slifstein M; Comley R; Salinas C; Johnson CN; Jakobsen S; Houle S; Laruelle M; Cunningham VJ; Martarello L
    J Nucl Med; 2012 Feb; 53(2):295-303. PubMed ID: 22223878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biodistribution of [11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist.
    Van der Mey M; Windhorst AD; Klok RP; Herscheid JD; Kennis LE; Bischoff F; Bakker M; Langlois X; Heylen L; Jurzak M; Leysen JE
    Bioorg Med Chem; 2006 Jul; 14(13):4526-34. PubMed ID: 16517171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of serotonin 5-HT(4) receptor mRNA and ligand binding sites in the post-mortem human brain.
    Bonaventure P; Hall H; Gommeren W; Cras P; Langlois X; Jurzak M; Leysen JE
    Synapse; 2000 Apr; 36(1):35-46. PubMed ID: 10700024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
    Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
    Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
    Leysen JE; Janssen PM; Megens AA; Schotte A
    J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arene- and quinoline-sulfonamides as novel 5-HT7 receptor ligands.
    Zajdel P; Marciniec K; Maślankiewicz A; Paluchowska MH; Satała G; Partyka A; Jastrzębska-Więsek M; Wróbel D; Wesołowska A; Duszyńska B; Bojarski AJ; Pawłowski M
    Bioorg Med Chem; 2011 Nov; 19(22):6750-9. PubMed ID: 22001327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
    Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
    J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.
    Hirst WD; Stean TO; Rogers DC; Sunter D; Pugh P; Moss SF; Bromidge SM; Riley G; Smith DR; Bartlett S; Heidbreder CA; Atkins AR; Lacroix LP; Dawson LA; Foley AG; Regan CM; Upton N
    Eur J Pharmacol; 2006 Dec; 553(1-3):109-19. PubMed ID: 17069795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585.
    East SZ; Burnet PW; Leslie RA; Roberts JC; Harrison PJ
    Synapse; 2002 Sep; 45(3):191-9. PubMed ID: 12112397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907.
    Hall H; Farde L; Halldin C; Lundkvist C; Sedvall G
    Synapse; 2000 Dec; 38(4):421-31. PubMed ID: 11044889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer.
    Lemoine L; Andries J; Le Bars D; Billard T; Zimmer L
    J Nucl Med; 2011 Nov; 52(11):1811-8. PubMed ID: 21990574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.
    Ishibashi T; Horisawa T; Tokuda K; Ishiyama T; Ogasa M; Tagashira R; Matsumoto K; Nishikawa H; Ueda Y; Toma S; Oki H; Tanno N; Saji I; Ito A; Ohno Y; Nakamura M
    J Pharmacol Exp Ther; 2010 Jul; 334(1):171-81. PubMed ID: 20404009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.
    Cussac D; Duqueyroix D; Newman-Tancredi A; Millan MJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):168-77. PubMed ID: 12110994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities.
    Schaffhauser H; Mathiasen JR; Dicamillo A; Huffman MJ; Lu LD; McKenna BA; Qian J; Marino MJ
    Biochem Pharmacol; 2009 Oct; 78(8):1035-42. PubMed ID: 19549510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.